PharmEng Opens Offices, Announces $1.7m U.S. Contract In North Carolina
Toronto, Ontario - PharmEng International Inc., a full-service consulting and contract manufacturing company, today announced the opening of the Raleigh office in North Carolina. Concurrent with the opening, the Company announced the hiring of a Director for the USA operation and the securing of over US$1.7 M in contracts for the N. Carolina operations.
The Raleigh office is situated on the edge of North Carolina's Research Triangle Park, home to over 100 research and development-oriented companies including pharmaceutical, biotechnology and biopharmaceutical organizations. The area is strategic to the central east coast region of the USA. Located approximately five miles from Raleigh Durham International Airport, the Raleigh location provides convenient access and cost-efficient travel allowing access to other major pharmaceutical and biotechnology hubs such as Washington DC and the Piedmont Triad area.
To head up the offices, Shelley Preslar has been hired as Director, Raleigh, Pharmaceutical and Biotechnology Division - joining the PharmEng USA Inc. division on September 26, 2005. Ms. Preslar will be instrumental in the start-up and expansion of the offices both locally and in related sectors throughout the USA. Prior to joining PharmEng, Shelley Preslar was the South East USA Senior Project Manager for a Regulatory and Validation Compliance Consulting firm.
The Raleigh offices, through the wholly owned subsidiary PharmEng USA Inc., have been awarded a contract for services exceeding US$1.7 M over the ensuing year. This commitment is expected to grow into additional services provided by PharmEng.
"Our company has consistently demonstrated that we can compete successfully in the international marketplace. Our people, with their depth of knowledge, provide our clients with invaluable access to a wide range of subject matter experts." commented Alan Kwong, CEO and Chairman of PharmEng International Inc. "We are the added bench strength when our clients need to go deep in the regulatory and validation compliance arena." concluded Mr. Kwong.
SOURCE: PharmEng International Inc.